← Insider buys
FULC

Fulcrum Therapeutics, Inc. · Healthcare

Chief Scientific Officer Owen B. Wallace sold $122K of Fulcrum Therapeutics, Inc.

Sold$121,760
$20.00Price
6,088Shares
−5%Stake

What FULC did after the filing

Prices for FULC after this filing aren't in yet.

Traded Wed, Feb 19. Filed Thu, Feb 20, 11:23 AM ET, during the session. Not investment advice.